Wu, Zhao-xin
Wang, Chen-jing
Shi, Ping
Liu, Yan-ping
Li, Ting
Sun, Fei-fei
Fu, Yao
Gao, Xiao-meng
Ma, Ya-ping
Clinical trials referenced in this document:
Documents that mention this clinical trial
Pharmacokinetics and Bioequivalence of Abiraterone Acetate Tablets in Healthy Chinese Volunteers: An Open, Randomized, Single-Dose, Three-Period, Three-Sequence Crossover Study
https://doi.org/10.1007/s40268-023-00418-6
Funding for this research was provided by:
National Major Science and Technology Projects of China (2020ZX09201-018, 2020ZX09201-025, 2017ZX09304-024)
Article History
Accepted: 14 March 2023
First Online: 3 April 2023
Declarations
:
: This study passed the Medical Ethics Committee of the Affiliated Hospital of Qingdao University review on 13 September 2017, and approval was obtained (no. QYFYEC 2017–057-01). Written informed consent was obtained from all participants.
: Not applicable.
: The data supporting the conclusions of this article are included within the article and its additional file.
: This study adheres to the Consolidated Standards of Reporting Trials (CONSORT) guidelines and includes a completed CONSORT checklist as an additional file.
: Zhao-xin Wu, Chen-jing Wang, Ping Shi, Yan-ping Liu, Ting Li, Fei-fei Sun, Yao Fu, Xiao-meng Gao, Ya-ping Ma, Yu Cao declare no conflicts of interest.
: Test execution and data collection in this work were supported by grants from the National Major Science and Technology Projects of China Special Project for ‘Significant New Drugs Development’ (2020ZX09201-018, 2020ZX09201-025, 2017ZX09304-024).
: This study was designed by YC. CJW and ZXW contributed equally to this work. PS, YPL,TL, FFS, YF, YPM and XMG performed the research, and all authors read and approved the manuscript.